La contratación, mediante Acuerdo Marco con un único empresario, del suministro sucesivo del medicamento de terapia avanzada Lisocabtagén maraleucel, en tratamiento individual por paciente.
TED · 600560-2026Award noticeawardedNo deadline given
Value
Estimated€20,708,160 · 20,708,160 EUR
Awarded€20,708,160 · 20,708,160 EUR
WinnerBRYSTOL MYERS SQUIBB, S.A.U
Who already wins at this buyer
Firms with recorded awards from Servizo Galego de Saúde in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| AMGEN, S.A | JANSSEN-CILAG, S.A. | SANOFI-AVENTIS, S.A. | PFIZER S. L.U | 1 | €59,539,295 | 2026-07-08 |
| Laboratorios ViiV Healthcare, S.L. | 1 | €1,980,000 | 2026-05-06 |
Full buyer profile: what Servizo Galego de Saúde buys and who wins it →
CPV codes
33652100 Medical equipment & pharmaceuticalsDescription
Suministro sucesivo de medicamentos para el tratamiento de segunda línea del Linfoma B difuso de células grandes